Read + Share
Amedeo Smart
Independent Medical Education
Gershenson DM, Gourley C, Paul J. MEK Inhibitors for the Treatment of Low-Grade Serous Ovarian Cancer: Expanding Therapeutic Options for a Rare Ovarian Cancer Subtype. J Clin Oncol 2020 Sep 8:JCO2002190. doi: 10.1200/JCO.20.02190.PMID: 32897828
Email
LinkedIn
Facebook
Twitter
Privacy Policy